Asuka Nishimura
Overview
Explore the profile of Asuka Nishimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
999
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harada M, Motoike Y, Nomura Y, Nishimura A, Koshikawa M, Watanabe E, et al.
Int J Cardiol
. 2025 Jan;
422:132954.
PMID: 39755334
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) reportedly decreased the new-onset atrial arrhythmias in patients with type-2 diabetes (T2DM) or heart failure (HF). This study examined the impact of SGLT2is on...
2.
Koshikawa M, Harada M, Nomura Y, Nishimura A, Motoike Y, Watanabe E, et al.
Heart Rhythm O2
. 2024 Sep;
5(8):520-528.
PMID: 39263611
Background: Different energy sources of balloon-based ablation for pulmonary vein isolation cause different kinds of endothelial damage and coagulation responses associated with thromboembolic risk. Objectives: The study sought to compare...
3.
Jia J, Wilson W, Karmaker A, Nishimura A, Otsuka H, Ohara K, et al.
Stem Cells Dev
. 2023 Dec;
33(3-4):57-66.
PMID: 38062993
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) hold great potential in regenerative medicine. These cells can be expanded indefinitely in theory and are able to differentiate...
4.
Harada M, Okuzaki D, Yamauchi A, Ishikawa S, Nomura Y, Nishimura A, et al.
PLoS One
. 2023 Apr;
18(4):e0283942.
PMID: 37014905
Background: Circulating microRNAs (miRNAs, miR) have been considered as biomarkers reflecting the underlying pathophysiology in atrial fibrillation (AF). Nevertheless, miRNA expression in the peripheral blood samples might not reflect a...
5.
Nishimura A, Harada M, Ashihara T, Nomura Y, Motoike Y, Koshikawa M, et al.
Heart Vessels
. 2022 Nov;
38(5):699-710.
PMID: 36436027
Persistent atrial fibrillation (PeAF) may develop arrhythmogenic substrates of rotors/multiple wavelets. However, the ways in which pulmonary vein isolation (PVI) affects the dynamics of rotor/multiple wavelets in PeAF patients remain...
6.
Takanashi H, Kajiya-Kanegae H, Nishimura A, Yamada J, Ishimori M, Kobayashi M, et al.
Plant Cell Physiol
. 2022 May;
63(7):901-918.
PMID: 35640621
The awn, a needle-like structure extending from the tip of the lemma in grass species, plays a role in environmental adaptation and fitness. In some crops, awns appear to have...
7.
Nomura Y, Harada M, Motoike Y, Nishimura A, Koshikawa M, Ito T, et al.
Pacing Clin Electrophysiol
. 2022 Apr;
45(5):619-628.
PMID: 35383970
Background: Left-ventricular systolic dysfunction (LVSD) comorbid with atrial fibrillation is reversible, but recovery is limited in a subset of patients. The Selvester QRS (S-QRS) score is an electrocardiogram-based assessment that...
8.
Takeda M, Baba S, Okuma J, Hirose Y, Nishimura A, Takata M, et al.
Commun Biol
. 2022 Mar;
5(1):247.
PMID: 35318423
Enzymatic breakdown is an attractive cellulose utilisation method with a low environmental load. Its high temperature operation could promote saccharification and lower contamination risk. Here we report a hyper-thermostable cellobiohydrolase...
9.
Motoike Y, Harada M, Ito T, Nomura Y, Nishimura A, Koshikawa M, et al.
J Cardiovasc Electrophysiol
. 2021 Mar;
32(6):1620-1630.
PMID: 33694206
Background: Ablation index (AI) linearly correlates with lesion depth and may yield better therapeutic performance in pulmonary vein isolation (PVI) when tailored to a patient's wall thickness (WT) in the...
10.
Harada M, Motoike Y, Nomura Y, Nishimura A, Koshikawa M, Murayama K, et al.
J Cardiovasc Electrophysiol
. 2020 Aug;
31(11):2889-2897.
PMID: 32786019
Introduction: Silent cerebral events (SCEs) are related to the potential thromboembolic risk in atrial fibrillation (AF) ablation. Periprocedural uninterrupted oral anticoagulation (OAC) reportedly reduced the risk of SCEs, but the...